首页> 外文期刊>Journal of genetic counseling >Informed choice in direct-to-consumer genetic testing (DTCGT) websites: A content analysis of benefits, risks, and limitations
【24h】

Informed choice in direct-to-consumer genetic testing (DTCGT) websites: A content analysis of benefits, risks, and limitations

机译:直接面向消费者的基因测试(DTCGT)网站中的明智选择:收益,风险和局限性的内容分析

获取原文
获取原文并翻译 | 示例
           

摘要

An informed choice about health-related direct-toconsumer genetic testing (DTCGT) requires knowledge of potential benefits, risks, and limitations. To understand the information that potential consumers of DTCGT services are exposed to on company websites, we conducted a content analysis of 23 health-related DTCGT websites. Results revealed that benefit statements outweighed risk and limitation statements 6 to 1. The most frequently described benefits were: 1) disease prevention, 2) consumer education, 3) personalized medical recommendations, and 4) the ability to make health decisions. Thirty-five percent of websites also presented at least one risk of testing. Seventy-eight percent of websites mentioned at least one limitation of testing. Based on this information, potential consumers might get an inaccurate picture of genetic testing which could impact their ability to make an informed decision. Practices that enhance the presentation of balanced information on DTCGT company websites should be encouraged.
机译:有关健康相关的直接对消费者的基因检测(DTCGT)的明智选择需要了解潜在的好处,风险和局限性。为了了解DTCGT服务的潜在消费者在公司网站上暴露的信息,我们对23个与健康相关的DTCGT网站进行了内容分析。结果表明,利益声明超过风险和限制声明6比1。最经常描述的利益是:1)疾病预防,2)消费者教育,3)个性化医疗建议以及4)做出健康决定的能力。 35%的网站还存在至少一种测试风险。百分之七十八的网站提到至少一项测试限制。根据这些信息,潜在的消费者可能会获得不正确的基因测试图片,这可能会影响他们做出明智决定的能力。应鼓励在DTCGT公司网站上增强平衡信息呈现的做法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号